Table 2.
Functional data ([35S]GTP-γ-S) for N-phenethyl-substituted ortho-a and para-a racemates 5 and 10 and for ortho-b and para-b enantiomers 16a, 16b, 19a, and 19b
![]() Ke (nM)a | ||||
---|---|---|---|---|
Cmpd | R1 | R2 | μ-Antagonism | κ-Antagonism |
rac 5 | OH | H | 274 ± 49 | 163 ± 29 |
rac 10 | H | OH | 23 ± 10 | 46 ± 9 |
16a: (+)-4R,6aS,11bR | H | OH | 47 ± 9 | 100 ± 3 |
16b: (−)-4S,6aR,11bS | H | OH | 227 ± 33 | 103 ± 17 |
19a: (−)-4S,6aR,11bS | OH | H | 328 ± 67 | 761 ± 191 |
19b: (+)-4R,6aS,11bR | OH | H | 31 ± 6 | 22 ± 6 |
Naloxone | 2.3 ± 0.3 | - | ||
norBNI | - | 0.11 ± 0.02 |
[35S]GTP-γ-S binding was performed using CHO hMOR cells which express the human μ-opiate receptor, and were conducted as described in section 4.2.1. All values n=3.